Stockreport

Biomea Fusion Spotlights Durable Diabetes Data, Oral GLP-1 Weight-Loss Program at Oppenheimer Conf. [Yahoo! Finance]

Biomea Fusion, Inc.  (BMEA) 
PDF treated for three months continued to have declining A1C for months after stopping therapy, and Biomea has filed two follow-on studies (COVALENT-211 and COVALENT-212) wi [Read more]